Research Interests
Cell based therapies for acute postoperative kidney injury
Longitudinal assessment of perioperative diastolic dysfunction
Optimization pathways for improving surgical outcomes
Improving healthcare resource utilization by reducing waste in perioperative medications
Longitudinal assessment of perioperative diastolic dysfunction
Optimization pathways for improving surgical outcomes
Improving healthcare resource utilization by reducing waste in perioperative medications
Selected Grants
A randomized, multi-centric, placebo-controlled, participant and investigator-blinded study to evaluate the safety, tolerability and efficacy of TIN816 in adult patients at risk for acute kidney injury following cardiac surgery
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2023 - 2027Integrated Training in Anesthesiology Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1996 - 2026Examining Confidence Ratings in MOCA Minute
ResearchMentor · Awarded by Foundation for Anesthesia Education and Research · 2023 - 2025Accuryn Registry Study
Clinical TrialPrincipal Investigator · Awarded by Potrero Medical, Inc · 2021 - 2024A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Adaptive, Parallel Group Clinical Study to Evaluate the Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery
Clinical TrialPrincipal Investigator · Awarded by Guard Therapeutics International AB · 2023 - 2024Astellas AKI study
Clinical TrialPrincipal Investigator · Awarded by Astellas Pharma Global Development, Inc · 2019 - 2022A Multi-center, Randomized, Case-controlled, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 therapy) in COVID-19 Subjects with Acute Kidney Injury Receiving Renal Replacement Therapy
Clinical TrialPrincipal Investigator · Awarded by Sentien Biotechnologies, Inc. · 2020 - 2022Sentien SB-101
Clinical TrialPrincipal Investigator · Awarded by Sentien Biotechnologies, Inc. · 2017 - 2022Angion AKI
Clinical TrialPrincipal Investigator · Awarded by Angion Biomedica Corp. · 2016 - 2022Quark 309
Clinical TrialPrincipal Investigator · Awarded by Quark Pharmaceuticals, Inc · 2018 - 2021Evaluation of eGFR, Determined by Cystatin C and Creatinine, and mGFR, Measured by Iohexol Clearance, in Subjects at High Risk for Acute Kidney Injury (AKI) Following Cardiac Surgery
Clinical TrialPrincipal Investigator · Awarded by Quark Pharmaceuticals, Inc · 2020 - 2021Quark Pharmaceuticals
Clinical TrialPrincipal Investigator · Awarded by Quark Pharmaceuticals, Inc · 2016 - 2018External Relationships
- NC Council for Developmental Disabilities
- US2.AI
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.